Insight Briefs30 October 2025 Implications of Assessing Overall Survival in Oncology Studies The FDA’s August 2025 draft guidance reshapes oncology clinical trials by requiring pre-specified overall survival (OS) analysis in... Learn more
Insight Briefs7 August 2025 Optimizing eCOA in Oncology Trials: Patient-Focused Data Capture for Cancer Research Oncology leads clinical innovation with 7,747 trials registered through 2022, yet only 7% of cancer patients participate. This... Learn more
